Its a strength of claims arguement, SLA believe it is not just a vitamin. TGA has given approval subject to how it is currently being sold.
Now if SLA believed it was just a vitamin then they would sell it as such with vitamins! SLA have higher claims but not western trial results as you are aware only non western trial results.
Therefore hurdles for them to jump with the TGA which can't be done without further western trials. My understanding, but may be a little off. My view is Bio A going nowhere fast unless western trials and changes with TGA or relaxation by TGA because of non western trials.... Ropren is the registered pharmaceutical that will drive business or not in the mean time. Any other views.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.857M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42000 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1245 | 1 |
View Market Depth
| Last trade - 07.03am 14/07/2025 (20 minute delay) ? |
| SLA (ASX) Chart |
Day chart unavailable